Stock Chart

NCNA

$1.09 -6.84%
Score: 40.0 HOLD
Pro
Screener
Vol: 2.20x (vs SPY: 2.2x | vs QQQ: 2.1x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Oct 02, 2026
No qualifying chart pattern in the trailing 60 sessions — we only flag setups that pass our quality gate.
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About NCNA - NuCana plc American Depositary Share

NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.

Key Statistics

Market Cap $5M
P/E Ratio 0.02

This NCNA stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track NCNA's price movements with trendlines, gamma walls, and key support/resistance levels.